Corporate Banner
Satellite Banner
Technology Networks Header
Monday, December 22, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

4SC Reports Positive Topline Data from Clinical Phase I Trial with 4SC-205
Friday, December 12, 2014
4SC-205 is the only oral inhibitor of the Eg5 kinesin protein in clinical development worldwide. Eg5 plays a crucial role in cell division and tumour growth.

Alizé Pharma Announces Positive Results for AZP-531
Thursday, December 11, 2014
Based on these results, a Phase Ib trial has been launched in type 2 diabetes patients.

USP Chapters <232>, <233> and <2232> for Trace Elements
Thursday, December 11, 2014
Thermo Scientific has compiled an online guide to the new USP chapters.

Parkinson's Vaccine: EU-Team Launches Clinical Trial
Wednesday, December 10, 2014
Vaccine candidate based on proprietary technology by AFFiRiS AG.

TxCell Announces Start of Phase IIb Clinical Trial with Ovasave®
Tuesday, December 09, 2014
Top line results of this study are expected end 2016/early 2017.

VAXIMM Reports Positive Follow-On Data from Oral Cancer Vaccine Trial
Friday, December 05, 2014
Phase I study evaluating safety and tolerability of VXM01 in pancreatic cancer.

Vetter Adds Flexible Serialization Service to its Portfolio
Thursday, December 04, 2014
A new service allowing for the explicit identification of drug packaging.

Evotec and Sanofi Enter into Exclusive Negotiations
Thursday, December 04, 2014
Goal to improve innovation effectiveness in drug discovery and pre-clinical development.

Catalent and Valerion Therapeutics Collaborate
Thursday, December 04, 2014
Collaboration to bring new treatments for orphan genetic disorders to market.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 3316
SELECTBIO
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn